Get the Stockscreener App
0.3428
1.24%
0.0042
Milestone Scientific Inc. stock is traded at $0.3428, with a volume of 42,027.
It is up +1.24% in the last 24 hours and down -14.36% over the past month.
Milestone Scientific, Inc. develops computer-controlled anesthetic delivery devices for the medical and dental markets in the United States and internationally. The company operates through dental and medical segments. Its products include CompuDent System used to control the flow rate of the anesthesia during the injection that allows virtually painless injections for various dental procedures, including routine fillings, implants, root canals, and crowns; and CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances. CompuFlo also includes a disposable injection handpiece for the tactile control during the injection; CompuFlo Epidural, a computer controlled anesthesia system for use in various medical applications; CompuFlo Intra-Articular, a computer controlled injection system for administering corticosteroids and other medicaments; CompuMed for use in various applications, such as plastic, hair restoration, podiatry, colorectal, dermatology, orthopedics, and various other surgeries. Its products also comprising Cosmetic Botulinum Injection device for the pain free injection of botulinum toxin; Veterinary Nerve Block Anesthesia device; the Wand Single Tooth Anesthesia System; and other devices. Milestone Scientific, Inc. was founded in 1989 and is headquartered in Livingston, New Jersey.
See More
Previous Close:
$0.3386
Open:
$0.3385
24h Volume:
42,027
Relative Volume:
0.36
Market Cap:
$31.06M
Revenue:
$8.90M
Net Income/Loss:
$-4.57M
P/E Ratio:
-6.1655
EPS:
-0.0556
Net Cash Flow:
$-1.84M
1W Performance:
-4.78%
1M Performance:
-14.36%
6M Performance:
+28.97%
1Y Performance:
-27.14%
1-Day Range:
$0.3205
$0.3429
1-Week Range:
$0.30
$0.3751
52-Week Range:
$0.2181
$0.5796
Milestone Scientific Inc. Stock (MLSS) Company Profile
Name
Milestone Scientific Inc.
Sector
Industry
Phone
973-535-2717
Address
220 South Orange Avenue, Livingston, NJ
Compare MLSS vs ISRG, BDX, RMD, ALC, MDLN
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MLSS
Milestone Scientific Inc.
|
0.3428 | 31.06M | 8.90M | -4.57M | -1.84M | -0.0556 |
ISRG
Intuitive Surgical Inc
|
426.24 | 150.58B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
192.66 | 52.48B | 21.37B | 1.41B | 3.07B | 3.9437 |
RMD
Resmed Inc
|
241.44 | 33.96B | 5.54B | 1.52B | 1.74B | 10.37 |
ALC
Alcon Inc
|
66.64 | 32.21B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
36.59 | 32.10B | 29.14B | 1.07B | 1.05B | 1.1956 |
Milestone Scientific Inc. Stock (MLSS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-16-20 | Initiated | Northland Capital | Market Perform |
| Nov-16-18 | Reiterated | Maxim Group | Buy |
| Dec-23-16 | Reiterated | Maxim Group | Buy |
| Dec-11-15 | Initiated | Maxim Group | Buy |
Milestone Scientific Inc. Stock (MLSS) Latest News
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Friday's pre-market session: top gainers and losers - ChartMill
Milestone Scientific Highlights Building a Scalable Growth Platform for CompuFlo® Medical Business - marketscreener.com
AtaiBeckley's Final Chapter: Shareholders Trade Certainty for Milestone-Linked Upside - AD HOC NEWS
Core Scientific Wins Conditional ERCOT Approval for 1,402 Megawatts in Texas - Minichart
Milestone Scientific (NYSE: MLSS) opens path to raise up to $45M - stocktitan.net
Thermo Fisher (NYSE: TMO) insider uses stock to cover taxes instead of selling on market - Stock Titan
Milestone Scientific Earnings Call Highlights CompuFlo Surge - TipRanks
Milestone Scientific Achieves Debt-Free Balance Sheet Through Debt-to-Equity Conversion by Three Directors - mymalonetelegram.com
Milestone Scientific Achieves Debt-Free Balance Sheet Through Debt-to-Equity Conversion by Three Directors - The Manila Times
Milestone Scientific Achieves Debt-Free Balance Sheet Through Debt-to-Equity Conversion by Three Directors - Moomoo
Earth’s oceans reach a milestone scientists say may be unprecedented in millennia - yahoo.com
Milestone (MIST) Snapshot: Ends Higher by 0.97% at $1.04 in Latest Trading; Next Session: Traders Can Monitor the $0.99-$1.09 Range on the DayMomentum Surge Alerts - careplusvn.com
Milestone (MLSS) Quarter in Focus: EPS Prints Above Forecast; Price Reaction: Shares Move 4.67% Down in the Available RecordEPS Estimate Trend - https://www.dars.gov.et/
Core Scientific (CORZ) legal chief sells 10,000 shares - Stock Titan
Benchmark reiterates Speculative Buy on Milestone Scientific stock By Investing.com - Investing.com Australia
MLSS Q1 2026 Earnings: Narrower-than-Expected Loss Highlights Cost Discipline Despite Revenue UncertaintyNon-GAAP Earnings - vinanet.vn
Benchmark reiterates Speculative Buy on Milestone Scientific stock By Investing.com - Investing.com Nigeria
Benchmark reiterates Speculative Buy on Milestone Scientific stock By Investing.com - Investing.com Australia
Benchmark reiterates Speculative Buy on Milestone Scientific stock By Investing.com - Investing.com South Africa
Benchmark reiterates Speculative Buy on Milestone Scientific stock By Investing.com - Investing.com South Africa
Benchmark reiterates Speculative Buy on Milestone Scientific stock By Investing.com - Investing.com Canada
Benchmark reiterates Speculative Buy on Milestone Scientific stock - Investing.com
Benchmark reiterates Speculative Buy on Milestone Scientific stock - Investing.com
Transcript: Milestone Scientific Q2 2026 Earnings Conference Call - Sahm
Milestone Scientific’s Global Exposure: Geopolitical and China Risks Threaten Supply Chain and Revenue - TipRanks
Milestone Scientific Inc (MLSS) (Q2 2026) Earnings Call Highligh - GuruFocus
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Milestone Scientific Releases Q2 2026 Financial Results - news.alphastreet.com
Milestone Scientific Q3 Sales Guidance Misses $2.510M Estimate - scanx.trade
Earnings call transcript: Milestone Scientific posts Q2 2026 revenue growth By Investing.com - Investing.com India
Earnings call transcript: Milestone Scientific posts Q2 2026 revenue growth By Investing.com - Investing.com Nigeria
Earnings call transcript: Milestone Scientific posts Q2 2026 revenue growth By Investing.com - Investing.com Australia
MLSS: Q2 revenue up 22% year-over-year, medical segment surges, 2026 guidance reaffirmed - TradingView
Earnings call transcript: Milestone Scientific posts Q2 2026 revenue growth - Investing.com
Earnings call transcript: Milestone Scientific posts Q2 2026 revenue growth By Investing.com - Investing.com UK
Transcript: Milestone Scientific Q2 2026 Earnings Conference Call - Benzinga
Milestone Scientific Inc. Reaffirms Earnings Guidance for the Year Ending December 31, 2026 - marketscreener.com
Milestone Scientific Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Milestone Scientific Reports 231% Growth in Medical Revenue, Announces VA and DoD Distribution Agreement and Reaffirms 2026 Outlook - Quiver Quantitative
Milestone Scientific Reports Financial Results for Second Quarter 2026 - marketscreener.com
Press Release: Milestone Scientific Reports Financial Results for Second Quarter 2026 - Moomoo
Milestone Scientific Reports 231% Growth in Medical Revenue, Announces VA and DoD Distribution Agreement and Reaffirms 2026 Outlook | MLSS Stock News - Quiver Quantitative
Milestone Scientific Inc (MLSS) (Q2 2026) Earnings Call Highlights: Revenue Surges 22% on ... - Yahoo Finance
Milestone Scientific Q2 revenue up 22%; affirms FY26 guidance - scanx.trade
Milestone Scientific (NYSE: MLSS) grows revenue 22% but flags going concern risk - Stock Titan
Milestone Scientific Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Earnings To Watch: Milestone Scientific Inc (MLSS) Q2 2026 -- GF Value Sees 13% Upside - finance.yahoo.com
Earnings To Watch: Milestone Scientific Inc (MLSS) Q2 2026 -- GF Value Sees 13% Upside - GuruFocus
What To Expect From Milestone Pharmaceuticals Inc (MIST) Q2 2026 Earnings - Yahoo Finance
Milestone Scientific Inc. Stock (MLSS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Milestone Scientific Inc. Stock (MLSS) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| BP4 S.r.l. | 10% Owner |
Oct 23 '25 |
Sale |
0.43 |
80,000 |
34,416 |
8,996,765 |
| BP4 S.r.l. | 10% Owner |
Oct 22 '25 |
Sale |
0.45 |
14,427 |
6,488 |
9,076,765 |
| BP4 S.r.l. | 10% Owner |
Oct 21 '25 |
Sale |
0.44 |
40,000 |
17,592 |
9,091,192 |
| BP4 S.r.l. | 10% Owner |
Oct 20 '25 |
Sale |
0.45 |
24,034 |
10,880 |
9,131,192 |
| BP4 S.r.l. | 10% Owner |
Oct 14 '25 |
Sale |
0.54 |
30,000 |
16,185 |
9,155,226 |
| BP4 S.r.l. | 10% Owner |
Oct 13 '25 |
Sale |
0.55 |
10,000 |
5,500 |
9,175,226 |
| BP4 S.r.l. | 10% Owner |
Oct 10 '25 |
Sale |
0.55 |
10,158 |
5,588 |
9,185,226 |
| BP4 S.r.l. | 10% Owner |
Oct 08 '25 |
Sale |
0.47 |
30,000 |
13,950 |
9,195,384 |
| BP4 S.r.l. | 10% Owner |
Oct 07 '25 |
Sale |
0.45 |
10,000 |
4,500 |
9,225,384 |
| BP4 S.r.l. | 10% Owner |
Oct 03 '25 |
Sale |
0.45 |
19,210 |
8,636 |
9,235,384 |
2.70%
0.92%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):